Sources

10 Total Sources

Merck, Moderna Win Phase III Melanoma Trial in 1,137 Patients, Advancing Personalized mRNA Vaccines

Oncodaily1d ago
Merck, Moderna INTerpath-001 Phase III Trial Meets Melanoma Endpoints
The Washington Post1d ago
Moderna, Merck mRNA Vaccine Succeeds in Melanoma Trial, Paving Way for Other Cancers
The Spokesman Review1d ago
A melanoma vaccine was hailed as a breakthrough. Which cancers are next?
BioSpace1d ago
The Future of Cancer Treatment Lies in Vaccines, Say These Pioneers - BioSpace
linkedin1d ago
mRNA-LNP Vaccine Suppresses Mammary Tumor Development | Helix Biotech, Inc. posted on the topic | LinkedIn
NPR1d ago
A personalized cancer vaccine that fights melanoma : NPR
Facebook1d ago
Moderna and Merck said a late-stage trial of a personalized cancer treatment based on the mRNA technology behind Covid-19 vaccines met its goals in treating melanoma, potentially marking a major | CNN
The Globe and Mail1d ago
Moderna and Merck's cancer vaccine raises new treatment hope - The Globe and Mail
24/7 Wall St.1d ago
Moderna Sinks 18% After 177% Cancer Vaccine Rally, BioNTech Falls 4%, Merck Slips - 24/7 Wall St.
National Institutes of Health (NIH) (.gov)1d ago
SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade - PMC